INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
RS

Rich Stuart

Director, Chief Medical OfficerCIK 0001841785

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells5 / 0
Max Insider Score52
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
RS
Rich StuartDirector, Chief Medical Officer
TENXTENAX THERAPEUTICS, INC.
Grant or award
A—
250.0K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    TENAX THERAPEUTICS, INC.Director, Chief Medical Officer · Dec 5, 2025
37
RS
Rich StuartDirector, Chief Medical Officer
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY
$26K
2,500 sh
Dec 9, 2025
Dec 10, 2025
traded Dec 9, 2025
+1d
SEC FORM 4

Evidence

37
RS
Rich StuartDirector, Chief Medical Officer
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$25K
2,500 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence

42
RS
Rich StuartDirector, Chief Medical Officer
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$23K
2,500 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC FORM 4

Evidence

52
RS
Rich StuartDirector, Chief Medical Officer
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$9,006
1,000 sh
Dec 2, 2025Dec 5, 2025
traded Dec 2, 2025
+3dSEC FORM 4

Evidence

42
RS
Rich StuartDirector, Chief Medical Officer
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$14K
1,500 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC FORM 4

Evidence